openPR Logo
Press release

Drug Eluting Balloon Market to Witness Significant Growth During the Forecast Period

06-12-2019 02:59 PM CET | Industry, Real Estate & Construction

Press release from: DataM Intelligence 4Market Research

Drug Eluting Balloon Market to Witness Significant Growth

DataM Intelligence 12 Jun 2019
Dallas, USA
The market report titled ‘Global Drug Eluting Balloon Market - Size, Share and Forecast (2019 - 2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.

Drug Eluting Balloon Market Drivers
The global drug eluting balloon market is primarily driven by increasing demand for drug-coated balloons over the standard Percutaneous Transluminal Angioplasty (PTA), balloons for treating peripheral and coronary arterial diseases. In addition, the market growth is also expected to be high due to rapidly increasing technological advancements in drug eluting balloon.
The rising prevalence of heart diseases and the ageing population are key factors driving the growth of drug eluting balloon market. For instance, according to the Centers for Disease Control and Prevention (CDC), more than 15 million Americans suffer from coronary heart disease, which makes it the most common type of heart disease, which results in the deaths of over 370,000 people, annually. In most cases, the progression of CADs (Coronary Artery Diseases) becomes clinically apparent by the age of 40. However, the patients aged 65 years or more account for approximately 85% of the total deaths from CAD.

Request for the free sample of the report - https://www.datamintelligence.com/research-report/drug-eluting-balloon-market

Drug Eluting Balloon Market Segmentation
On the basis of product type, peripheral drug eluting balloon, the peripheral drug eluting balloon segment accounted for the largest market share in 2018 and expected to dominate over the forecast period (2019-2026). The segment is growing due to growing usage of drug eluting balloon in the treatment of peripheral artery diseases as these devices are easy to use and the treatment shows improved patency rate as compared to that of standard PTA balloons. In addition, the growth of the peripheral drug eluting balloon segment attributed to the increasing development in these devices by major players.
On the basis of drug coating technology, the FreePac segment held the largest market share in 2018 and growing at a significant CAGR over the forecast period due to entry of several new drug coating technologies in the market.

Drug Eluting Balloon Market Regional Analysis
In Asia-Pacific, the market size of drug eluting balloon market is contributed by major countries such as China, and India. The region is growing due to several initiatives taken by governments to increase awareness about therapeutic applications of drug-eluting balloons in coronary and peripheral artery diseases. In addition, the aging population and increased investments by many foreign medical device companies fuelled the growth of the drug-eluting balloons market in the region. According to UN, approximately 30% of the total population in China is estimated comprise elderly people by 2050. Developing countries, such as India and China, are expected to have a larger geriatric population base compared to developed countries, such as the U.S. For instance, the number of people aged above 60 years is expected to reach 437 million in China and 324 million in India compared to 107 million in the U.S. by 2050. Hence, the demand for drug eluting balloon devices is increasing in this region, leading to the growth of the market.
Drug Eluting Balloon Market Company Trends
Some of the major players in the Drug Eluting Balloon market include Medtronic, Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Biotronik, Acotec Scientific, among others. The key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with the increased focus on R&D are other ways the leading players improve their market presence.

To know more information about the report - https://www.datamintelligence.com/research-report/drug-eluting-balloon-market

Table of contents overview -
1.Global Drug Eluting Balloon Market Methodology and Scope
2.Global Drug Eluting Balloon Market – Market Definition and Overview
3.Global Drug Eluting Balloon Market – Executive Summary
4.Global Drug Eluting Balloon Market – Market Dynamics
5.Global Drug Eluting Balloon Market – Industry Analysis
6.Global Drug Eluting Balloon Market – By Product Type
7.Global Drug Eluting Balloon Market – By Drug Coating Technology
8.Global Drug Eluting Balloon Market – By End-Users
9.Global Drug Eluting Balloon Market – By Region
10. Global Drug Eluting Balloon Market – Competitive Landscape
11. Company Profiles
12. Global Drug Eluting Balloon Market – Premium Insights
13. Global Drug Eluting Balloon Market – DataM

Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

Email
info@datamintelligence.com

Phone
+1 877-441-4866

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historical data but also allows a highly justifiable forecast model.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Eluting Balloon Market to Witness Significant Growth During the Forecast Period here

News-ID: 1773244 • Views:

More Releases from DataM Intelligence 4Market Research

Automotive Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Automotive Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031 …
Market Overview Global Automotive Testing Market reached USD million in 2022 and is projected to witness lucrative growth by reaching up to USD million by 2030. The market is growing at a CAGR of 4.2% during the forecast period (2023-2030). The automotive testing industry encompasses a range of assessments involving complete vehicles, components, and systems. These evaluations occur across various settings, including laboratories, virtual simulations, and real-world scenarios. The primary objective of
Ankle Replacement Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
Ankle Replacement Devices Market Size, Share, Industry, Forecast and outlook (20 …
Global Ankle Replacement Devices Market to Witness Substantial Growth by 2031, Forecasts Research The global ankle replacement devices market, which reached a value of US$ million in 2023, is projected to exhibit significant expansion, reaching US$ million by 2031, according to a recent market analysis conducted by [Research Company]. The market is anticipated to grow at a notable CAGR during the forecast period spanning from 2024 to 2031. Ankle replacement devices, also
Carbon Dioxide Monitor Market Size, Share, Industry, Forecast and outlook (2024-2031)
Carbon Dioxide Monitor Market Size, Share, Industry, Forecast and outlook (2024- …
Global Carbon Dioxide Monitor Market Projected to Reach $ Million by 2031, Indicating a Steady Growth Trajectory The worldwide carbon dioxide monitor market witnessed significant growth in 2023, reaching a valuation of US$ million. Forecasts indicate a promising upward trend, with expectations to hit US$ million by 2031, boasting a Compound Annual Growth Rate (CAGR) of during the forecast period spanning 2024 to 2031. Carbon dioxide monitors, also known as CO2 detectors
United States Prosthetic Contact Lenses Market Size, Share, Growth, Forecast and Outlook (2024-2031)
United States Prosthetic Contact Lenses Market Size, Share, Growth, Forecast and …
United States Prosthetic Contact Lenses Market Projected to Expand Significantly by 2031 The United States Prosthetic Contact Lenses Market, which achieved a valuation of US$ billion in 2023, is anticipated to witness substantial growth, reaching US$ million by 2031. This growth trajectory reflects a robust Compound Annual Growth Rate (CAGR) during the forecast period from 2024 to 2031. Prosthetic contact lenses are meticulously designed to enhance the aesthetic appearance of the eye

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug